Westlake Village, CA, August 28, 2023 – FlemingMartin is pleased to announce that Genelux, a late clinical-stage public company developing a pipeline of next-generation oncolytic viral immunotherapies, has hired Lourie Zak as its Chief Financial Officer.

Lourie joins Genelux with an extensive background in CFO roles, including Guitar Center Brands, Sonifi Solutions, and PBS Biotech. She started her biotech career at Amgen where she progressively moved into more senior positions, including Executive Director Finance, Global Commercial Operations. Lourie brings years of accounting and financial management expertise to her role at Genelux as the company continues to execute its operating plan, which includes building a commercially ready team and supporting the potential launch of Olvi-Vec.

Genelux Genelux is a Phase 3 biopharmaceutical company developing powerful therapeutics for patients suffering from difficult-to-treat cancers. The Company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor’s sophisticated defense mechanisms. To learn more, visit genelux.com.

FlemingMartin is a leading retained executive search firm with offices in Northern and Southern California. FlemingMartin partners with Boards, Venture Capital Firms, and CEOs to build successful, execution-focused management teams. The Firm’s principals are trusted advisors and business partners who enable companies to gain powerful, far-reaching, and lasting contributions from their executive-level human capital. flemingmartin.com